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ABSTRACT 
Diabetic patients' numbers are increasing around the world, this metabolic disease affects pa-
tient's quality of life in all domains: physically, socially, psychologically and emotionally. As the 
disease progresses patients need to use insulin. According to the Palestinian MOH (Ministry of 
Health) 12% of people in Palestine have diabetes. Twenty percent of type 2 diabetic patients visit 
the MOH clinics and use insulin also 12% use both insulin and oral drugs to control their blood 
glucose levels. These patients administer insulin subcutaneously by vial and syringe. The aim of 
this study was to assess QoL (quality of life) of diabetic patients using insulin, factors affecting it, 
preference of patients to use insulin pen and their willingness to pay for them. Method: A descrip-
tive study conducted with a sample of 311 diabetic patients that use vial/syringe to administer insu-
lin and attending MOH diabetic clinics in Bethlehem and Hebron. A questionnaire was designed to 
assess four parts; socio-demographic part, patient's health profile, QoL part and willingness to pay 
for insulin pens part. QoL was measured using SF-36v2® questionnaire and the willingness to pay 
part validated using pilot study. Results were analyzed using Quality Metric Health Outcomes™ 
Scoring Software 4.0 and SPSS software. Results and conclusion: The mean scores of QoL do-
mains ranged from 40.7 to 65.6. Diabetic patients had lower scores than general population in all 
domains of QoL; physical functioning, role-physical, body pain, general health, vitality, role-
emotional, mental health, physical composite summary and mental composite summary, except in 
social functioning. The majority of participants had lower scores than general population in all QoL 
domains. The results revealed that gender, age and glycemic control, number of family members, 
duration of insulin use had no significant impact on QoL. Approximately 77% of participants re-
ported having complications, which had a significant negative effect on their QoL (P-value < 0.001 
in all domains). Single patients and patients living in Hebron had a significant positive effect on 
QoL. Higher level of education, high monthly income and being employed had a positive effect on 
QoL while longer duration of diabetes had negative effect. Eighty-five percent of participants pre-
ferred to use insulin pens if it was available as a choice in the MOH; 35% of them were willing to 
pay extra money to get insulin pens instead of vial/syringe. This study revealed that the QoL of 
diabetic patients using insulin in this sample was low, which could be increased if the government 
included insulin pens in the MOH drug list. 
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INTRODUCTION 
The number of diabetic patients is in-
creasing around the world. It was estimated 
using 133 studies from 91 countries that the 
number of diabetic patients will increase 
from 2010 to 2030 by 54%, the number in 
developing countries was expected to in-
crease by 69%, while in developed countries 
by 20% [1]. 
In the Palestinian West Bank the preva-
lence of diabetes was 15.3%  in 2010 and is 
expected to increase to 23.4% by 2030 [2]. 
According to the Palestinian MOH (Ministry 
of Health) the number of deaths caused by 
diabetes complications was 869 in 2015, 
which is estimated to be 19.7 out of 100.000 
[3].  
With the increase in number of people 
with diabetes, caring for those patients is 
considered a global challenge. They make a 
huge effort and many decisions every day 
and all day long to reach a non-diabetic me-
tabolism rate, which will affect social, physi-
cal and emotional aspects of life. So, the 
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evaluation of QoL (Quality of Life) in these 
patients is essential to measure psychosocial 
well-being, the benefits of new treatments 
and to identify the dissatisfaction of the exist-
ing treatments.  
Quality of life was defined by the WHO 
(World Health Organization) in 1947 as the 
perception of the individual's position in life, 
including the person's satisfaction of physical 
health, psychological health and social rela-
tionships [4, 5].  Quality of life defined also 
as the personal evaluation of how good or 
bad their life is. It evaluates the satisfaction 
of person's life in many aspects including 
psychological, environmental, social and 
physical. HRQoL (Health related Quality of 
Life) concerns of health aspects as well as 
general QoL; it is the patient's perception of 
the effect of illness or treatments on their 
QoL, these two concepts, QoL and HRQoL, 
are used interchangeable [5]. 
Many studies indicated that QoL was 
lower in diabetic patients than other popula-
tion [6]. In Gaza diabetic patients had lower 
scores than non-diabetics in all QoL do-
mains; physical, psychological, environmen-
tal and social relationships [7]. In North West 
Bank a recent study found that 30% of type 2 
diabetic patients had poor general health and 
moderate pain [8], while within type 1 dia-
betic patients a recent study showed that the 
mean score of QoL ranged from 51.7% to 
75.6%, the highest scores were in the bodily 
pain domain and the lowest in general health 
domain. Those results were lower than QoL 
of type 1 diabetes in other populations [9].  
Diabetic Patients from two clinics, Al-Watani 
Hospital and Al-Makhfyah primary health 
care clinic in Nablus were studies it was 
found that older age being unemployed and 
the presence of comorbidities were associated 
with lower QoL. On the other hand treatment 
satisfaction was not associated with HRQoL 
[10].   
Studies have found that the presence of 
complications have a negative effect on QoL 
of diabetic patients [11-13]. Quality of life 
was also found to be affected by many fac-
tors; HbA1c levels, number of insulin injec-
tions, type of diabetes, duration of diabetes, 
monthly income and age  [6, 7, 9, 12, 14-17].  
In order to achieve glycemic control 
multiple daily injections of insulin are rec-
ommended for patients. Many patients treat-
ed with insulin fear the needles, lack suffi-
cient diabetes education and deny the need 
for insulin, all these reasons contribute to the 
non-adherence in those patients [18, 19]. 
Many studies have also found that the QoL of 
diabetic patients can be improved by the use 
of insulin pens for insulin delivery [20, 21]. 
Many studies assessed the preference of 
patients to use insulin pens over syringe/vial 
and found that most patients preferred the use 
of insulin pens when they had used both [13, 
22, 23]. 
The aim of our study was to describe the 
QoL of diabetic patients that use insulin in 
the MOH clinics in Bethlehem and Hebron 
and to identify important variables that affect 
QoL for these patients.  The secondary aim 
was to assess the preference of diabetic pa-
tients for insulin pens and the amount of 
money they are willing to pay for them.   
METHODS 
Study population 
This was a cross sectional study among 
diabetic patients that use insulin in Bethle-
hem and Hebron MOH clinics. The target 
population for this study was diabetic pa-
tients that use insulin by vial/syringe and at-
tend the MOH clinics in Bethlehem and Heb-
ron. Ethical Approval for this study was ob-
tained from Palestinian Ministry of Health 
(Reference number 1035/56 3/10/2016). Min-
istry of health facilities have purposely cho-
sen based on the high percentage of diabetic 
patients attending these health care facilities. 
Inclusion criteria for patients were: Diabetic 
patients using insulin by vial/syringe, diag-
nosed with type 1 or 2 diabetes and being 17 
years old and more (both male and female). 
Exclusion criteria were patients who did not 
agree to participate; patients use only oral 
hypoglycemic drugs and patients using insu-
lin pens during the time of the study. 30 pa-
tients were recruited to perform a pilot study 
of the WTP (willingness to pay) domain in 
order to test if it was appropriate and clear for 
the patients.  
Our sample was 311 patients. All eligi-
ble patients were approached as they came in 
for routine follow-ups during the data collec-
tion period in the primary health clinics. Pa-
tients who met the study inclusion criteria 
were asked if they were willing to participate 
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in the study by completing the questionnaire 
while they were waiting to see the doctor. 
Verbal consent was obtained from each pa-
tient prior to completing the questionnaire. 
The interview with participants needed from 
15 to 20 minutes.  
Questionnaire 
In our study, we used a questionnaire of 
four parts; socio-demographic, health profile, 
quality of life and willingness to pay. The 
socio-demographic information sheet covered 
the following areas of interest:  Gender, age, 
educational level, occupation, marital status, 
residency and income status. Health profile 
part included duration of diabetes, duration of 
insulin use, type of diabetes, HbA1c (gly-
cated hemoglobin) level, type of treatment, 
incidence of hypoglycemia, insulin dosage 
regimen and presence of complications.  
The Palestinian version of SF-36v2® 
Health Survey was used to assess quality of 
life for diabetic patients using insulin. The 
Non-Commercial License Agreement was 
obtained from OptumInsight Life Sciences 
incorporation (OPTUM). SF-36v2 is a valid 
survey that has been used in many studies. 
The certificate of Arabic (for Palestine) of the 
SF-36v2® Health Survey was obtained from 
the OPTUM incorporation. We used the eight 
domains measured by SF-36; physical func-
tioning (PF), role physical (RP) which is role 
limitation due to physical health issues, bodi-
ly pain (BP), general health (GH), vitality 
and energy (VT), social functioning (SF), 
role emotional (RE) that is role limitation due 
to emotional problems and mental health 
(MH) to assess quality of life. Also the two 
summary components were used that are 1- 
physical component summary (PCS), which 
represents physical limitations, disabilities 
and the presence of fatigue and body pain. 2- 
The mental component summary (MCS), 
which evaluates psychological distress and 
limitations due to emotional problems. The 
scoring range of the eight scales ranges is 
from 0 to 100, higher scores indicates a better 
quality of life. 
WTP survey was used in this study to 
examine the patient's preference for the insu-
lin pens and their willingness to pay for those 
pens. 
 
 
Data analysis 
The questionnaires were filled and the 
data for QoL part were introduced in the 
Quality Metric Health Outcomes™ Scoring 
Software 4.0. The results were in a scale of 0 
to 100. These results from the software were 
introduced into the SPSS program. A one-
way Analysis of Variance (ANOVA) was 
used to compare differences between sub-
groups of independent categorical variables. 
Post-hoc analyses (Scheffé’s Post hoc Test) 
was then conducted to test for differences 
between the groups to determine if the over-
all ANOVA was statistically significant. For 
interpretation of the results, P <0.05 was 
considered to be statistically significant. Con-
fidence intervals were calculated at the 95% 
level of confidence. Multiple regression 
analysis was used to test which variables sig-
nificantly predicted PCS and MCS. 
RESULTS 
Socio-economic and health profile  
The sample used was 311 patients distributed 
as 114 patients in Bethlehem and 196 patients 
in Hebron Socio-economic information 
summary of the sample is presented in Table 
1.  
Table )1): distribution of the participants by 
socio-demographic characteristics. 
Variable  
Fre-
quency 
Per-
cent 
Age, years 
17-40 78 25.3% 
41-59 120 38.9% 
>60  110 35.7% 
Gender 
Female 162 52.1% 
Male 149 47.9% 
Marital 
status 
Married 264 84.9% 
Widow 21 6.8% 
Single 25 8.0% 
Divorced 1 0.3% 
Education 
level 
No 
schooling        
110 
35.% 
Elemen-
tary and 
secondary 
school 
160 
51.% 
Diploma 15 4.8% 
Profes-
sional  
26 
8.4% 
Employ-
ment sta-
tus 
Full time- 
job 
47 
15.% 
Part time- 
job 
17 
5.5% 
No work 246 79.% 
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Most subjects 269 patients (86.5%) had 
type 2 diabetes and 42 (13.5%) had type 1. 
Almost 50% (169) of the subjects reported 
that they had hypoglycemia in the past four 
weeks. When patients were asked about their 
insulin regimen, 210 (67.5%) of participants 
reported they used insulin two times daily, 71 
(22.8%) three times and 30 (9.6%) once dai-
ly. The mean level of HbA1c was 9% with a 
standard deviation of 2. The majority of pa-
tients (97%) (254 patients) had HbA1c level 
of 7 and higher while only 3% (8 patients) 
had HbA1c level of less than 7. 
The duration of diabetes ranged from 
less than a year to 59 years with a mean of 
14.9 years (±SD 13.6). The average duration 
of using insulin was 6.6 years. Sixty-seven 
(21.6%) of patients reported they had one 
complication, 74 (23.8%) reported two com-
plications and 98 (31.4%) reported from 3 to 
7 complications. The most frequent compli-
cation between patients was visual disorders 
(58%, 180 patients), followed by neurologi-
cal disorders (42%, 51 patients), heart disease 
(31%, 97 patients), stroke (22%, 67 patients), 
renal complications (16%, 51 patients) and 
foot ulcers (14%, 42 patients). The least 
common complication was gangrene. On the 
other hand, 70 patients (23%) reported they 
had no complications of diabetes. 
QoL scores 
The mean scores of the quality of life 
domains are shown in table 2. The domain 
with the highest score was social functioning 
(M = 65.6, ±SD 36.2), followed by physical 
functioning (M= 58.91, ±SD 31.2) and role 
emotional (M = 58.91, ±SD 34.58). The low-
est was vitality (M = 40.7, ±SD). The mean 
score for physical component summary was 
lower than mental component summary. The 
percentage of patients that had scores above 
the general population norms appears rela-
tively low for all domains (ranging from 12% 
to 30%). 
Table (2): Mean scores of participants' quality of life domains, standard deviation and percentages 
of participants whose scores were above or below the general population norm. 
Domains Mean SD 
Above the gen-
eral population 
norms* (%) 
Below the gen-
eral population 
norms (%) 
PCS (Physical Component Summary) 
(PCS) 
41.42 11.67 17 63 
PF (Physical Functioning) 58.92 31.2 19 56 
RP (Role Physical) 44.25 36.72 17 68 
BP (Bodily Pain) 49.03 32.64 21 60 
GH (General Health) 48.3 22.0 12 58 
MCS (Mental Component Summary) 41.32 12.19 15 59 
VT (Vitality) 40.73 27.01 18 59 
SF (Social Functioning) 65.61 36.23 43 45 
RE (Role Emotional) 58.91 34.59 30 60 
MH (Mental Health) 54.25 24.33 16 62 
* U.S general population norms.
Factors affecting QoL  
There was no significant relationship be-
tween gender and QoL domains except for 
body pain in which men had a higher score 
than women. Age also didn't affect QoL do-
mains. The mean score of all domains was 
higher for patients in Bethlehem relative to 
Hebron (3 points difference in MCS and PCS 
between patients in Bethlehem and Hebron, 
p-value < 0.05). Single patients had higher 
scores in all domains compared to married 
and widow (13 points difference in PCS, p-
value < 0.001). Participants who were illit-
erate had lower mean scores in all domains 
than those who had primary or secondary 
education, diploma and university level of 
education (12 points difference in PCS and 7 
points in MCS between patients that are illit-
erate and who have a university degree, p-
value < 0.05). There was a significant posi-
tive relationship between working and QoL 
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(8 points difference in PCS between patients 
that have a full-time job and who are unem-
ployed, p-value 0.000). On the other hand, 
there was no significant relationship between 
the place of living; village, city or camp and 
QoL domains, QOL was not also affected by 
the number of family members. Participants 
with higher income had a higher mean QoL 
scores (14-20 points difference in PF, SF and 
RE, p< 0.05). 
 The mean scores for PF, RP, BP and 
PCS QoL domains were lower in patients 
who had been diagnosed with diabetes for 
longer duration. The differences between pa-
tients had diabetes for less than 6 years and 
who had it for more than 10 years were: 16 
points in PF, 16 points in RP, 11 points in BP 
and 7 points in PCS (p-value < 0.05), the 
worst values were reached after 10 years. The 
duration of using insulin didn't affect QoL 
scores. The mean scores for all QoL domains 
except MH, MCS and RE, were significantly 
higher for type 2 diabetes patients than type 1 
(p-value < 0.05). There was no significant 
relationship between QoL and HbA1c levels. 
The only domain that was significantly af-
fected by the insulin regimen was GH with a 
5 points difference between once and three 
times regimen. The mean scores for all QoL 
domains were significantly higher for pa-
tients with lower number of complications 
(15 points in PCS and 13 points in MCS dif-
ference between patients had no complica-
tions and who had more than 4 complica-
tions, p-value<0.001). 
Multiple regression analysis was used to 
test which variables significantly predicted 
PCS. The results indicated that the type of 
diabetes, duration of diabetes, level of educa-
tion and employment were significant predic-
tors of PCS (p-value < 0.05). These four pre-
dictors explained 26.9% of the variance in 
PCS; type of diabetes caused 14.2% of the 
variance followed by duration of diabetes 
(5.8%), level of education (4.7%) and em-
ployment (2.2%). On the other hand, MCS 
was significantly predicted by level of educa-
tion. 
Willingness to Pay  
181 of subjects (58.2%) reported that if 
both choices pens and syringes were availa-
ble they will choose pens and 130 (41.8%) 
will choose syringes. 130 (41.8%) of partici-
pants didn’t answer the question if they are 
willing to pay more for the pens, 110 (35.4%) 
reported they will and 71 (23%) reported that 
they will not pay more. 
As shown in table 3, the most common 
two reasons reported by participants for 
choosing pens were that they are easier to use 
and inject than syringes. On the other hand, 
the majority of patients 166 (92%), who 
chose vial/syringe reported that they chose 
vials because they are used to them.  
Table (3): Reasons reported by patients for 
choosing pens and syringes. 
What was 
important to 
you when 
you chose 
pens? 
Reasons 
Easier to use 
% of pa-
tients 
92% 
Easier to inject 87% 
More accurate in 
measuring the 
dose. 
66% 
Need less time 
for the injection 
70% 
Causes less pain 65% 
More lifestyle 
and social life 
flexibility 
82% 
Reading the dose 
is easier 
79% 
What was 
important to 
you when 
you chose 
vial/syringe 
used to it 92% 
Less cost 72% 
Hard to learn to 
use pens 
34% 
Easy to use vials 81% 
Easy to inject by 
syringe 
73% 
Feel more confi-
dent about the 
dose accuracy 
64% 
Less painful 34% 
Syringes don’t 
interfere with 
daily activities 
69% 
Easy to read the 
dose 
77% 
Believe to be 
more able to con-
trol blood sugar 
77% 
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DISCUSSION  
The results of this study agrees with a 
previous study assessed QoL of type 2 dia-
betics in North West Bank [8]. They are also 
consistent with other studies examined QoL 
in diabetic patients and found that diabetes 
mellitus affected health-related quality of life 
of the participants [6, 24]. When compared to 
a study in New Delhi, all domains except 
general health were lower in our study [25]. 
Also, compared to a recent study in Saudi 
Arabia, the scores of QoL were lower in all 
domains except social functioning compared 
to the Saudi patients' scores [26]. 
We found no significant relationship be-
tween glucose control (HbA1c levels) and 
QoL, which was consistent with most studies 
that found no relationship between glucose 
control and QoL [27, 28]. Complications had 
a very clear negative significant effect on all 
QoL domains, many other studies showed a 
negative impact of complications on QoL [7, 
12, 13]. This study found that the mean 
scores of QoL domains were higher for type 
2 than type 1 diabetes, which is consistent 
with other studies [15], The differences be-
tween the two types could be due to the dif-
ferences in age and treatment regimens [28]. 
In all QoL domains, patients with a monthly 
income more than $880 scored better than 
patients with income less than $880  this was 
consistent with a study that found that diabet-
ic patients who had more than $530 monthly 
income had better QoL than who have no 
regular income [7]. There was no significant 
relationship between gender and QoL except 
in BP domain, this result is consistent with 
other studies that assessed the QoL of diabet-
ic patients in Gaza [7]. In this study, it was 
found that better education was linked to bet-
ter QoL in all domains, which agreed with 
another study assessed QoL of diabetic pa-
tients using SF-20 [6]. Being employed was 
also associated with better QoL in all do-
mains, this result agrees with the findings of 
Eljedi et.al [7] in Gaza and with other studies 
[14]. These results could be due to the possi-
bility that educated people have better self-
esteem, better opportunity for employment, 
higher income and better social life. 
Fifty eight percent of patients preferred 
insulin pens over syringes to administer insu-
lin, these results are consistent with previous 
studies that assessed the preference of pa-
tients for insulin pens and more than 70% of 
patients preferred to use pens [22, 23]. Pa-
tients were not willing to make a substantial 
out-of-pocket payment might be because dia-
betic patients registered in the MOH clinics 
are used to pay only a co-payment out of 
pocket for the prescription each month. 
Several limitations of this study should 
be considered when these results are inter-
preted. The sample is collected from Hebron 
and Bethlehem so the results cannot be gen-
eralized to the Palestinian population. The 
patients are studied once, and the effect of 
using insulin pens is not studied. There is no 
controlled group of patients using insulin 
pens.  
CONCLUSIONS 
The majority of participants had lower 
QoL than the general population norms and 
the scores of all domains except the physical 
and social functioning were below 50, which 
indicated a low QoL. QoL of Diabetic pa-
tients using insulin was influenced by resi-
dency, marital status, level of education, em-
ployment, monthly income, diabetes dura-
tion, diabetes type, diabetes complications 
and insulin regimen. Most patients (58%) 
preferred to use pens if it was available as a 
choice for insulin administration. The num-
ber of diabetic patients in Palestine is increas-
ing. One of the main objectives of diabetes 
treatment program is to promote the QoL of 
diabetic patients. A close look at the health 
care system is needed in order to try to im-
prove QoL by possible introduction of insulin 
pens as a choice for diabetic patients using 
insulin. The introduction of insulin pens will 
make insulin self-administration easier and 
will decrease the discomfort of injection, 
which could increase the QoL, compliance 
and diabetes complications in the future and 
eventually reduce the overall health care 
costs. 
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